Coherus Narrows Its Oncology Bet as Cash Discipline Meets Two Phase 2 Readouts 4 days ago AnaIn Clinical TrialsFeatured AnalysisPharma Industry Updates
BeOne Medicines Raises 2026 Outlook as Brukinsa Drives Second-Quarter Growth 4 days ago AnaIn LeadersPharma Industry UpdatesTop Stories
FDA Drug Repurposing Forum Puts Evidence Standards and Patient Access in Focus 4 days ago AnaIn Clinical TrialsFDA ApprovalsFeatured AnalysisPharma Industry Updates
Moderna Starts Human Trial of mRNA Vaccine Against Bundibugyo Ebola 4 days ago AnaIn Breaking NewsClinical TrialsFeatured AnalysisInnovationTop Stories
China’s Biotech Model Is Moving From Asset Export to Integrated Drug Building 2 weeks ago AnaIn AI & DataBiopharma ManufacturingFeatured AnalysisInnovationPartnershipsTop Stories
The Biohaven Verdict Sends a Warning Through Biotech’s Confidential Deal Rooms 2 weeks ago AnaIn Featured AnalysisPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Bambusa’s Dual-Target Antibody Shows Early Atopic Dermatitis Activity After First Dose 2 weeks ago AnaIn Breaking NewsClinical TrialsInnovationResearch Updates
IDEAYA Expands IDE892 Study in MTAP-Deleted Pancreatic and Lung Cancers 2 weeks ago AnaIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
Novo Nordisk Escalates Ad War With Lilly, Seeks Court Order Over Dosing Comparisons 2 weeks ago AnaIn Pharma Industry UpdatesTop Stories
MannKind Wins FDA Approval for Furoscix ReadyFlow, Cutting Heart Failure Diuretic Therapy From Five Hours to Ten Seconds 2 weeks ago AnaIn Breaking NewsFDA ApprovalsInnovation
The Tariff Deadline Reshaping Where Pharma Makes Its Drugs 2 weeks ago AnaIn Biopharma ManufacturingFeatured AnalysisPharma Industry UpdatesTop Stories
Global CRO Market on Pace to Reach $140 Billion by 2031 as Sponsors Lean Harder on Outsourced Trial Capacity 3 weeks ago AnaIn AI & DataBiopharma HighlightsPharma Industry Updates
Drug Farm Raises $55 Million Series D to Advance Dual-Indication ALPK1 Programs 4 weeks ago AnaIn Clinical TrialsFunding RoundsVenture Capital
Inside the Fight Over Sean Kaufman: What a Vaccine Skeptic’s Nomination Reveals About HHS’s Next Chapter 4 weeks ago AnaIn Breaking NewsLeadersPharma Industry UpdatesTop Stories
ProMIS Neurosciences Reports First Human Evidence of Dose-Dependent Amyloid-Oligomer Reduction at AAIC 2026 4 weeks ago AnaIn BreakthroughsClinical TrialsResearch Updates
